Thus, it confirms the assumption that a deficiency of BMP9/10-ENG-ALK1-SMAD4 pathway is a possible mechanism of bAVMs development in HHT patients (Townson et al., 2012; Saito et al., 2017). This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.